[3] CDK4/6抑制剂治疗激素受体阳性人表皮生长因子受体2阴性乳腺癌临床应用专家共识(2023版)[4] 中国临床肿瘤协会CSCO乳腺癌诊疗指南2023[5]Grinshpun,A.,Tolaney,S.M.,Burstein, H.J. et al. The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative ...
CDK 4/6 Inhibitor CDK 4/6 Inhibitor CAS:1256963-02-6 纯度:98% 分子式:C22H29ClN8 分子量:440.97 保存:RT 外观:\N 品牌:源叶 货号:T19365-25mg 产品包装:25mg,100mg,1g 上海源叶生物科技有限公司(Shanghai yuanye Bio-Technology Co., Ltd)成立于2009年,是一家致力于各类生化试剂、标准品、小分子抑...
LY2835219是具有选择性的CDK4/6抑制剂,能够抑制CDK4/CDK6的活性,IC50分别为2nM和10nM。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:1231930-82-7 别名:ABEMACICLIB;CDK4/6 dual inhibitor 纯度:99.87% 分子式:C??H??F?N?O?S ...
Fig. 2 Distribution of AE of CDK4/6 inhibitorin different systemic organs NPT represented the number of PTs that generate a signal under the ROR combined with MHRA method; ROR025...
英文名 CDK 4/6 Inhibitor 化学名 4-[5-Chloro-3-(1-methylethyl)-1H-pyrazol-4-yl]-N-[5-[4-(dimethylamino)-1-piperidinyl]-2-pyridinyl]-2-pyrimidinamine 分子式 C22H29ClN8 CAS号 1256963-02-6 产品性状 No Data Available 分类 Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals,...
The increased and earlier use of CDK4/6 inhibitors has resulted in a better understanding of the mechanisms of acquired resistance; potential treatment combinations that might overcome these mechanisms are being explored. Treatment selection after disease progression on a CDK4/6 inhibitor remains an ar...
CDK4/6 抑制剂抑制细胞周期,从而诱导细胞凋亡,并且发现与抗肿瘤免疫有关。 三种CDK4/6抑制剂用于临床实践,并显示出高度一致的无进展生存结果,尽管其总体生存结果存在不一致。 不同CDK4/6抑制剂的毒性特征各不相同,允许根据个体患者的需求定制一定的治疗方案。
[9] Bidard FC, Hardy-Bessard AC, Dalenc F, et al. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2022...
CDK4/6/1 Inhibitor | MedChemExpress(MCE) 英文名称: 总访问: 73 国产/进口: 进口 半年访问: 1 产地/品牌: MedChemExpress(MCE) 产品类别: 生化试剂 规格: 电询 最后更新: 2024-11-4 货号: HY-112280 CAS 号: 2099128-41-1 参考报价: 电询 立即询价 电话咨询 ...
(5-chloro-4-[4-fluoro-2-(2-hydroxypropan-2-yl)-1-(propan-2-yl)-1 H-benzimidazol-6- yl]pyrimidin-2-yl)amino)-2,3-dideoxy-D-threo-pentitol; CDK-4/6-IN-6,Inhibitor,inhibit,CDK,Cyclin,Cyclin dependent kinase,CDK4/6 IN 6,CDK4/6IN6; CDK4/6-IN-6CDK4/CDK4/6-IN-66-IN-6;...